AMGEN INC — Director's Dealing 2012

May 1, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2012-04-27

Reporting Person: Bradway Robert A (Director, President and COO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-04-27	Common Stock	A	20938	—	Acquired	104228	Direct
2012-04-28	Common Stock	F	1401	$71.64	Disposed	102827	Direct
2012-04-29	Common Stock	F	1401	$71.64	Disposed	101426	Direct

Footnotes

F1: The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 4/27/2014, 4/27/2015 and 4/27/2016, respectively.

F2: These shares include the following RSUs granted under the Company's equity plans: 3,000 RSUs which fully vest on 4/28/2013; 6,000 RSUs which vest in two equal annual installments of 3,000 each commencing 4/26/2013; 3,000 RSUs which vest in two equal annual installments of 1,500 each commencing 4/26/2013; 21,000 RSUs which vest in two equal installments of 6,930 each on 4/25/2013 and 4/25/2014 and one installment of 7,140 on 4/25/2015; and 20,938 RSUs which vest in three installments of 6,909, 6,910 and 7,119 on 4/27/2014, 4/27/2015 and 4/27/2016, respectively. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.